🚀 Pfizer Surges 10.23% Intraday | Fifth Consecutive Winning Session | 18th Aug 2025

made headlines on Dalal Street today, rallying 10.23% intraday and surpassing its 50, 100, and 200-Day SMAs, marking strong technical momentum. This is the fifth consecutive session of gains, with the stock up 14% over the last five trading days. At 03:30 pm IST, Pfizer traded at ₹5,750, up 7.92% (₹422), with a market capitalization of ₹24,364 Cr. The company operates in manufacturing, marketing, trading, and export of pharmaceutical products. Its Goa facility and partnerships with third-party manufacturers support nationwide distribution through independent distributors. Key Metrics: • 52W Range: ₹3,701 – ₹6,451 • P/E: 30.13 | Sector P/E: 26.25 • P/B: 5.78 | Dividend Yield: 3.75% • ROE: 18.2% | ROCE: 19.94% | EPS: 41.91 Pfizer’s current momentum is notable, and the stock has attracted strong market attention. 💬 What do you think? Will this rally continue, or is a near-term correction possible? Comment below and share your views! Disclaimer: This document is prepared by SEBI RRA (Reg. No. INH000016649), solely for informational purposes. It does not constitute investment advice, trading recommendations, or an offer to buy/sell any securities. Information is based on sources deemed reliable but is not guaranteed for accuracy or completeness. No warranty, express or implied, is provided. Portions of this content may have been reviewed or refined using AI tools to enhance grammatical accuracy and sentence structure. Past performance is not indicative of future results. Investments are subject to market risks. Investors should consult a qualified financial advisor before making decisions. SEBI registration and NISM certification do not assure performance or returns. Any securities mentioned, if any, are purely illustrative and not recommendations.